🇺🇸 FDA
Pipeline program

ZIO-101-C (Darinaparsin)

SGC1002

Phase 1 small_molecule active

Quick answer

ZIO-101-C (Darinaparsin) for Advanced Solid Tumors is a Phase 1 program (small_molecule) at Alaunos Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Alaunos Therapeutics
Indication
Advanced Solid Tumors
Phase
Phase 1
Modality
small_molecule
Status
active

Clinical trials